Evidencia de seguridad de los opioides mayores y menores en las enfermedades reumáticas

Francisco-Hernández, FM; Santos-Soler, G.
Reumatol. clín. (Barc.) ; 2(supl.1): 10-17, mar. 2006. tab
Artículo en Español | IBECS (España) | ID: ibc-77622

Documentos relacionados

  1. Therapeutics in rheumatology and the kidney.
  2. Potential for biosimilars in rheumatology in Africa.
  3. [PHARAO study: drug treatment of inflammatory rheumatic diseases : Guideline-conform treatment with biologics follows availability of biosimilars].
  4. Discrepancies between clinical and pathological findings seen at renal biopsy in rheumatological diseases.
  5. [Standardized management of targeted drugs for rheumatism].
  6. Unpublished clinical trials of common rheumatic diseases.
  7. Bone Involvement in Patients with Spondyloarthropathies.
  8. [Peroral and transdermal application of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of regional musculoskeletal pain syndromes].
  9. [Prescription of analgesics in patients with rheumatic diseases in Germany : A claims data analysis. German version].
  10. Prescription of analgesics in patients with rheumatic diseases in Germany : A claims data analysis.